drugset / Trial / NCT00195494

Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis

NCT00195494

Phase 4 Completed 542 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the effects of the combination of ETN and MTX to MTX alone on radiographic change and clinical disease activity in subjects with early RA over 12 months.

Timeline

Start
2004-11
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etanercept Protein / enzyme biologic 50 mg Subcutaneous
Comparator Methotrexate Small molecule 20 mg Oral

Indications